BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19025902)

  • 1. Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.
    Feng Y; Jeong EK; Mohs AM; Emerson L; Lu ZR
    Magn Reson Med; 2008 Dec; 60(6):1347-52. PubMed ID: 19025902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor characterization with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in mice.
    Wu X; Feng Y; Jeong EK; Emerson L; Lu ZR
    Pharm Res; 2009 Sep; 26(9):2202-8. PubMed ID: 19597972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a biodegradable macromolecular contrast agent in dynamic contrast-enhanced MRI for assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy.
    Feng Y; Emerson L; Jeong EK; Parker DL; Lu ZR
    J Magn Reson Imaging; 2009 Aug; 30(2):401-6. PubMed ID: 19629979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers.
    Wu X; Jeong EK; Emerson L; Hoffman J; Parker DL; Lu ZR
    Mol Pharm; 2010 Feb; 7(1):41-8. PubMed ID: 19958031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents.
    Zong Y; Wang X; Jeong EK; Parker DL; Lu ZR
    Magn Reson Imaging; 2009 May; 27(4):503-11. PubMed ID: 18814987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice.
    Zong Y; Wang X; Goodrich KC; Mohs AM; Parker DL; Lu ZR
    Magn Reson Med; 2005 Apr; 53(4):835-42. PubMed ID: 15799038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.
    Cyran CC; Fu Y; Rogut V; Chaopathomkul B; Wendland MF; Shames DM; Brasch RC
    Acad Radiol; 2013 Oct; 20(10):1256-63. PubMed ID: 24029057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow versus permeability weighting in estimating the forward volumetric transfer constant (K
    Li CH; Chen FH; Schellingerhout D; Lin YS; Hong JH; Liu HL
    Magn Reson Imaging; 2017 Feb; 36():105-111. PubMed ID: 27989901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
    Li Y; Liu G; Lou X; Chen Z; Ma L
    Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent.
    Wang X; Feng Y; Ke T; Schabel M; Lu ZR
    Pharm Res; 2005 Apr; 22(4):596-602. PubMed ID: 15846467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF).
    Cyran CC; Sennino B; Fu Y; Rogut V; Shames DM; Chaopathomkul B; Wendland MF; McDonald DM; Brasch RC; Raatschen HJ
    Eur J Radiol; 2012 May; 81(5):891-6. PubMed ID: 21889860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model.
    Malamas AS; Jin E; Zhang Q; Haaga J; Lu ZR
    Pharm Res; 2015 Sep; 32(9):3029-43. PubMed ID: 25840948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, biodistribution and contrast enhanced MR blood pool imaging of Gd-DTPA cystine copolymers and Gd-DTPA cystine diethyl ester copolymers in a rat model.
    Feng Y; Zong Y; Ke T; Jeong EK; Parker DL; Lu ZR
    Pharm Res; 2006 Aug; 23(8):1736-42. PubMed ID: 16850267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
    Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
    Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
    Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
    Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.
    Kaneshiro TL; Ke T; Jeong EK; Parker DL; Lu ZR
    Pharm Res; 2006 Jun; 23(6):1285-94. PubMed ID: 16729223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice.
    de Lussanet QG; Langereis S; Beets-Tan RG; van Genderen MH; Griffioen AW; van Engelshoven JM; Backes WH
    Radiology; 2005 Apr; 235(1):65-72. PubMed ID: 15731376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes.
    Zong Y; Guo J; Ke T; Mohs AM; Parker DL; Lu ZR
    J Control Release; 2006 May; 112(3):350-6. PubMed ID: 16631270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights.
    Hompland T; Gulliksrud K; Ellingsen C; Rofstad EK
    Acta Oncol; 2013 Apr; 52(3):627-35. PubMed ID: 23126523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlative dynamic contrast MRI and microscopic assessments of tumor vascularity in RIP-Tag2 transgenic mice.
    Sennino B; Raatschen HJ; Wendland MF; Fu Y; You WK; Shames DM; McDonald DM; Brasch RC
    Magn Reson Med; 2009 Sep; 62(3):616-25. PubMed ID: 19526501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.